about
Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11/eotaxin-1The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complexActive monomeric and dimeric forms of Pseudomonas putida glyoxalase I: evidence for 3D domain swapping.Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entry.Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.Synergistic interactions between chemokine receptor elements in recognition of interleukin-8 by soluble receptor mimics.Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).Sulfation of the Human Cytomegalovirus Protein UL22A Enhances Binding to the Chemokine RANTES.Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1)Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.The structural role of receptor tyrosine sulfation in chemokine recognition.Ticks from diverse genera encode chemokine-inhibitory evasin proteins.Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.Synthesis of polymers and nanoparticles bearing polystyrene sulfonate brushes for chemokine binding.Comparison of backbone and tryptophan side-chain dynamics of reduced and oxidized Escherichia coli thioredoxin using 15N NMR relaxation measurements.Molecular recognition by secondary metabolites.Temperature-dependent spectral density analysis applied to monitoring backbone dynamics of major urinary protein-I complexed with the pheromone 2- sec-butyl-4,5-dihydrothiazole.NMR investigation of the binding between human profilin I and inositol 1,4,5-triphosphate, the soluble headgroup of phosphatidylinositol 4,5-bisphosphate.Regulation of Chemokine-Receptor Interactions and Functions.Proteomic Identification of Interferon-Induced Proteins with Tetratricopeptide Repeats as Markers of M1 Macrophage Polarization.Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.Correction: Ticks from diverse genera encode chemokine-inhibitory evasin proteinsMolecular basis for methoxyamine initiated mutagenesisIncreased protein backbone conformational entropy upon hydrophobic ligand bindingComparison of protein backbone entropy and beta-sheet stability: NMR-derived dynamics of protein G B1 domain mutantsNMR mapping of the recombinant mouse major urinary protein I binding site occupied by the pheromone 2-sec-butyl-4,5-dihydrothiazoleDivergent and site-selective solid-phase synthesis of sulfopeptidesPhosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2)Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responsesPhosphoproteomic characterization of the signaling network resulting from activation of chemokine receptor CCR2Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1Development of a scaffold displaying exoloops of RXFP1Semisynthesis of an evasin from tick saliva reveals a critical role of tyrosine sulfation for chemokine binding and inhibition
P50
Q27696273-F5C172F1-0220-4946-9977-1242F7056256Q27748872-476311C0-AE04-42E7-BC19-4E724731DD58Q34749570-80C9F8C8-A39A-4530-8729-87767E0AB399Q35194597-F4A90517-8AF5-4519-AA98-A06F34AFA81FQ35701745-7BEB27BC-7C5B-4990-9C96-5878B90FDA1FQ35842651-886D2446-2B43-420C-A99D-3BB5E794F009Q35922575-2854EFAE-25C9-4BFA-A8F2-AE7CBE13B5F4Q36367584-3BD9EE6D-247D-416D-BBAA-531750AF41E3Q36742094-59EDE2F6-620F-4832-A656-100FA73787B6Q37182315-913CFDE3-02ED-443F-BA51-32484A44F3A6Q38151741-5BFD82A1-CD83-4912-AB69-93FBA00EFA91Q38646647-D877B946-645F-4AB4-BB70-1AA548F78576Q40201591-36AA6CEE-D658-4F35-934A-3156C8EBF712Q40734493-80F5356C-438A-4423-B32C-D11F75843302Q44484559-621D02BA-3A8C-4741-8035-2155870E06CEQ44508600-E6A47C31-A211-4FB7-9027-CF84F08A3ABAQ44761958-F636F7BD-D83C-49E2-8478-71A60600BFA2Q46227190-C86EF74C-06B6-4852-B174-9BBBE0A2D4B7Q47098984-3CADA838-6D2B-4A00-9084-824FE52B0ED4Q52672417-6F04BAF1-B081-49EC-A297-05B6EF84774EQ53079307-17207629-A5E9-4272-911B-7947DB251313Q57471362-C590872E-7A43-4FD8-992B-2FCAD5CA8FDDQ57928791-A9C19535-799E-4F30-90CA-1D4795EA4B9DQ73227017-8D26343D-E696-4EA2-9D8D-12DE9046C18AQ73683614-8D6BC744-8403-4685-996A-27E8ACBF46D9Q78087859-A61832CB-BC95-40C9-9EF5-11E1F5337B90Q83921897-3F5A97BF-268E-48F1-B69F-ACA62515C45FQ86392279-AF24E549-5E59-4742-AB5E-FBF3E721E7A9Q90644569-2385F68A-1554-413A-AD2C-B6EA1BBFE4C4Q90665799-BA245F7B-F99B-4F1E-8DD0-90EA336AC6ADQ91520979-55583DE6-8CC7-46C9-B44D-9F2B9C44E15EQ92083363-99D3298B-02E6-4485-9409-6CE7D0144C59Q95567364-B7CF2CCA-042D-484C-B78C-5AE52BDB6C9FQ95932093-94C9C2B8-AD2B-4A36-946A-99F3F670C107
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin J. Stone
@ast
Martin J. Stone
@en
Martin J. Stone
@es
Martin J. Stone
@nl
Martin J. Stone
@sl
type
label
Martin J. Stone
@ast
Martin J. Stone
@en
Martin J. Stone
@es
Martin J. Stone
@nl
Martin J. Stone
@sl
prefLabel
Martin J. Stone
@ast
Martin J. Stone
@en
Martin J. Stone
@es
Martin J. Stone
@nl
Martin J. Stone
@sl
P106
P1153
7402473183
P31
P496
0000-0002-6468-4427